(S1 (S (NP (JJ M-CSF-dependent) (NN PKC)) (VP (VBZ Regulates) (NP (JJ NF-kappaB-targeted) (NNS Genes)))))
(S1 (S (S (NP (NN NF-kappaB)) (VP (VBZ induces) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ downstream) (NNS genes)) (, ,) (PP (VBG including) (NP (DT the) (NN IkappaB) (NN family)))))))) (. .)))
(S1 (S (S (PP (IN Among) (NP (DT the) (NN IkappaB) (NNS molecules))) (, ,) (NP (NN IkappaBalpha)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN induced) (PP (IN by) (NP (NP (NN NF-kappaB) (NN activation)) (PRN (-LRB- -LSB-) (NP (CD 40)) (-RRB- -RSB-))))))) (. .)))
(S1 (S (S (S (VP (VBG Having) (VP (VBN shown) (SBAR (IN that) (S (NP (NN PKC)) (VP (VBD regulated) (NP (NN NF-kappaB) (NN activity)) (PP (IN in) (NP (JJ M-CSF-stimulated) (NNS MDMs))))))))) (, ,) (NP (PRP we)) (ADVP (RB next)) (VP (VBD determined) (SBAR (IN whether) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (NN PKC) (NN activity)))) (VP (VBD decreased) (NP (NP (NN expression)) (PP (IN of) (NP (JJ NF-kappaB-regulated) (NNS genes))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VP (VBN treated) (NP (CC both) (NP (NNS MDMs)) (CC and) (NP (NN RAW) (CD 264.7) (NNS cells))) (PP (IN with) (NP (DT the) (NN PKC) (NN inhibitor) (NN Ro-31-8220))) (PP (IN for) (NP (CD 30) (NNS minutes)))) (CC and) (RB then) (VP (VBN stimulated) (PP (IN with) (NP (NN M-CSF)))))) (. .)))
(S1 (S (S (NP (NN IkappaBalpha) (NN gene)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NN qRT-PCR)))))) (. .)))
(S1 (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NNS Figures) (NP (NP (NN 6A)) (CC and) (NP (NN 6B)))))))) (, ,) (S (S (NP (NN M-CSF)) (VP (VBD enhanced) (NP (NN IkappaBalpha) (NN gene) (NN expression)))) (CC and) (S (NP (NP (NN PKC) (NN inhibition)) (PP (IN by) (NP (NN Ro-31-8220)))) (VP (VBD decreased) (NP (NP (NN IkappaBalpha) (NN gene) (NN expression)) (PP (IN in) (NP (CC both) (NP (NNS MDMs)) (CC and) (NP (NP (NN RAW) (CD 264.7) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN p) (NN <) (CD 0.01)) (-RRB- -RRB-)))))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NN PKC)) (VP (VBD affected) (NP (NP (JJ NF-kappaB-regulated) (NN gene) (NN expression)) (PP (IN in) (NP (NNS macrophages)))))))))))) (. .)))
(S1 (S (S (VP (TO To) (ADVP (RB further)) (VP (VB define) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN PKC))) (PP (IN in) (S (VP (VBG mediating) (NP (JJ human) (NN MDM) (NN survival)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN M-CSF)))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (JJ anti-apoptotic) (NN gene) (NN BCL-xL)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB also)) (VP (VBN regulated) (PP (IN by) (NP (NN NF-kappaB)))))))))))) (. .)))
(S1 (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NN Figure) (CD 6C)))))) (, ,) (NP (NN Ro-31-8220)) (VP (VBD reduced) (NP (JJ M-CSF-stimulated) (NN BCL-xL) (NN expression)) (PP (VBN compared) (PP (TO to) (NP (NP (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NP (NN M-CSF)) (CC and) (NP (NP (DT the) (NN vehicle) (NN control) (NN DMSO)) (PRN (-LRB- -LRB-) (NP (NN p) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))))) (. .)))
